Clinical effectiveness and safety of antazoline ‐based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short‐duration atrial fibrillation in the emergency department

ConclusionsIn selected patients with a stable CAD, even with a history of MI, antazoline ‐based CV of short‐duration AF may be an effective and safe therapeutic option.

Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Michal M. Farkowski, Aleksander Maciag, Malgorzata Zurawska, Ilona Kowalik, Hanna Szwed, Mariusz Pytkowski Tags: ORIGINAL RESEARCH ARTICLE Source Type: research